![5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone](https://static.cymitquimica.com/products/3D/img/XJB57393.png "Haga clic para ampliar")
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
CAS: 872573-93-8
Ref. 3D-XJB57393
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
Sinónimos:
- Ro-3306
- (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one
- 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- (Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one
- 2-[[(Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one
- (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one
Descripción:
Quizartinib is a targeted inhibitor of the protein kinase A-Raf signaling pathway and is used for the treatment of certain types of cancer. Quizartinib inhibits the polymerase chain reaction, which can lead to cell death. It also has inhibitory properties on some cancer cells by targeting her2+ breast cancer cells and inhibiting tumor growth in vivo models. Quizartinib has been shown to be effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and psoriasis. This drug also exhibits pluripotency markers that are similar to those found in embryonic stem cells.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
351.45 g/mol
Fórmula:
C18H13N3OS2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
